Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics: Twease.org

Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics: Twease.org PR Newswire ALBANY, New York, August 30, 2012 ALBANY, New York, August 30, 2012 /PRNewswire/ -- Twease.org - New Report Added in Biotechnology Reports Database Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics Mabs" and molecular tests are among the growth industries of pharmaceuticals and diagnostics, but they may have competition long-term from an unexpected source. Epigenomics is a potential game-changer in the clinical therapeutics market and significant in testing as well. It refers to technologies involving changes in genetic material that find their origins in causes other than base pairs alterations in the DNA of the host. Examples of such changes include DNA methylation and histone acetylation, both of which have been known for many years to cause changes in gene expression. This report Epigenomics, Present and Future Applications for Pharmaceuticals and Diagnostics describes the progress that has been made in our understanding of the basic science of epigenomics and considers the practical accomplishments being reported by the private sector. To Browse Full Toc Visit: http://www.twease.org/report/epigenomics-present-and-future-applications-for- pharmaceuticals-and-diagnostics.htm Epigenomics constitutes a challenge to the long held paradigm of DNA base pair sequences as the prime determinant of the phenotype.